Alpha-1 Antitrypsin Deficiency-associated Lung Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-01-17
Clinical Trial Update: NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease [Phase 1, Phase 2]
A Phase 1/2 trial of NTLA-3001 for Alpha-1 Antitrypsin Deficiency–associated lung disease has been withdrawn.